Tcm Group As · OMXCOP:TCM
Tcm Group As — Q2 2026 Earnings Presentation
9 slides from Tcm Group As's earnings presentation, Aug 20, 2026
Slide 1: TCM Group A/S Webcast Q2 2026
TCM Group A/S Webcast Q2 2026 August 20, 2026
Slide 2: Business update Q2 2026
Business update Q2 2026 ❑ Year on year revenue growth of 7.4%, with an organic growth of 0.6%. ❑ Revenue in Q2 of DKK 375 million vs. DKK 349 million last year. ❑ Continued positive sales development in Norway, +22.7% in Q2 vs. last year ❑ Total order-intake up on Q2 2025 due to growth in B2B and B2
Slide 3: Q2: Financial highlights
Q2: Financial highlights 1 Revenue: 375 mDKK (349 mDKK) 2 Organic growth: 0.6% Adjusted EBITA: 32.2 mDKK 3 (36,1mDKK) 4 Adjusted EBITA-margin: 8.6% (10.3%) 5 NWC ratio: -2.3% (-0.7%) 6 Cash conversion: 107% (79%) 3
Slide 4: Revenue in Q2 increased organically by 0.6%, year-on-year 7.4%
Revenue in Q2 Increased organically by 0.6%, with a year-on-year increase of 7.4% Revenue development 400 350 300 250 mDKK 200 362 375 349 333 150 308 289 100 50 0 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q2 comments: ❑ Organic revenue increase of 0.6%. ❑ Revenue growth in Denmark of 4.2%.- organic -4,1%
Slide 5: Margins maintained despite price pressure on raw materials and freight
Margins maintained despite price pressure on raw materials and freight Gross margin EBITA and EBITA margin 28,0% 26,0% 35,0 12,0% 24,3% 23,7% 23,80% 24,0% 23,3% 30,0 10,6% 10,0% 10,3% 21,1% 21,4% 22,0% 25,0 8,60% 8,0% 20,0% 20,0 mDKK 36,1 35,4 6,0% 6,4% 6,6% 32,2 15,0 6,3% 18,0% 26,1 4,0% 16,0% 10,0
Slide 6: NWC developing positive year-on-year, NIBD increased financing Celebert acquisition
NWC developing positive year-on-year, NIBD increased year-on-year financing Celebert acquisition. Net working capital Net interest-bearing debt Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 450 10 400 5 8 7 350 0 -4 300 -5 -9 250 mDKK -10 mDKK 200 417 397 372 -15 332 343 349 150 -20 100 -26 -25 50 -30 -32 0 Q
Slide 7: Strong cash flow and cash conversion in Q2 and YTD
Strong cash flow and cash conversion in Q2 and YTD Free cash-flow 60 50 40 30 mDKK 48 20 32 32 10 7 4 0 -4 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 -10 Q2 comments: ❑ Free cash flow was DKK 32m compared to DKK 32m in Q2 LY. ❑ Capex ratio was 1.1% of revenue compared to 1.2% in Q2 LY. ❑ Cash conversion (L
Slide 8: Guidance for 2026 maintained
Guidance for 2026 maintained Financial outlook: ❑ Net revenue: DKK 1,400-1,500 million ❑ Adjusted EBITA: DKK 120-140 million Revenue development Adjusted EBITA development Forward looking statements This presentation contains statements relating to the future, including statements regarding TCM Grou
Slide 9: Q&A
Q&A